These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 2175072)

  • 21. Antiphospholipid syndrome and cutaneous vasoocclusive disorders.
    Grattan CE; Burton JL
    Semin Dermatol; 1991 Sep; 10(3):152-9. PubMed ID: 1931563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lupus anticoagulant in neurology.
    el-Mallakh RS
    Bull Clin Neurosci; 1986; 51():102-7. PubMed ID: 3137986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sneddon's syndrome, anticardiolipin antibodies and anticardiolipin cofactor. A case report.
    Sinisi L; Palma V; Di Girolamo C; Scarpa R; Faccenda F; Rubba P; Cirillo S; Mansi D
    Acta Neurol (Napoli); 1992 Apr; 14(2):134-9. PubMed ID: 1414558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sneddon's syndrome and Willebrand's factor antigen].
    Kalashnikova LA; Nasonov EL; Baranov AA; Aleksandrova EN
    Klin Med (Mosk); 1994; 72(3):29-32. PubMed ID: 7990348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sneddon syndrome new clinical and immunological data].
    Kalashnikova LA; Chapman I; Nasonov EL; Korchin A; Aleksandrova EN; Shavit S; Reshetniak TM; Kosheleva NM
    Klin Med (Mosk); 1998; 76(6):34-8. PubMed ID: 9693498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiphospholipid antibodies in systemic lupus erythematosus: incidence, significance and relation to lupus nephritis].
    Zea Mendoza A; Rodríguez García A; Irigoyen Oyarzábal MV; Vázquez Díaz M; Pardo Vigo A; Mampaso FM; Ortuño Mirete J
    Med Clin (Barc); 1989 May; 92(19):724-8. PubMed ID: 2502695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of antiphospholipid antibodies in stroke.
    Coull BM; Levine SR; Brey RL
    Neurol Clin; 1992 Feb; 10(1):125-43. PubMed ID: 1556999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The antiphospholipid antibody syndrome: a new clinical and therapeutic viewpoint in systemic lupus erythematosus].
    Bravo-Vargas G; Lavalle-Montalvo C
    Gac Med Mex; 1988; 124(1-2):39-42. PubMed ID: 3145236
    [No Abstract]   [Full Text] [Related]  

  • 30. [Sneddon's syndrome [].
    Weber M
    Ann Dermatol Venereol; 1990; 117(12):923. PubMed ID: 2082785
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-phospholipid antibodies--their role in neurological diseases].
    Członkowska A
    Neurol Neurochir Pol; 1992; 26(2):217-23. PubMed ID: 1528381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies to phospholipids and to the coagulation proteins in AIDS.
    Abuaf N; Laperche S; Rajoely B; Carsique R; Deschamps A; Rouquette AM; Barthet C; Khaled Z; Marbot C; Saab N; Rozen J; Girard PM; Rozenbaum W
    Thromb Haemost; 1997 May; 77(5):856-61. PubMed ID: 9184392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.
    Cameron JS; Frampton G
    Pediatr Nephrol; 1990 Nov; 4(6):663-78. PubMed ID: 2128460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibodies--autoantibodies with a difference.
    Harris EN; Asherson RA; Hughes GR
    Annu Rev Med; 1988; 39():261-71. PubMed ID: 3130772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunologic disorders in cerebrovascular lesions associated with livedo (Sneddon's syndrome)].
    Kalashnikova LA; Zhirnova IG; Komel'kova LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):31-4. PubMed ID: 2718660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of antiphospholipid autoantibodies in lupus erythematosus].
    Pozsonyi T; Lakos G; Jakab L; Baraczka K; Jánoskuti L; Kleiber M; Sipka S; Pajor A; Szegedi G
    Orv Hetil; 1998 Oct; 139(40):2363-8. PubMed ID: 9796352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sneddon's syndrome--clinical course and out-come.
    O'Riordan JI; Javed M; Murphy R; Hutchinson M
    Ir Med J; 1995; 88(2):66-7. PubMed ID: 7775150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid antibodies and Sneddon's syndrome.
    Vargas JA; Yebra M; Pascual ML; Manzano L; Duŕantez A
    Am J Med; 1989 Nov; 87(5):597. PubMed ID: 2816979
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies.
    Berard M; Boffa MC; Karmochkine M; Aillaud MF; Juhan-Vague I; Francès C; Cacoub P; Piette JC; Harlé JR
    J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.